reference/13537577

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13537577

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	20
issn	0920-1211
pageRange	13-20
publicationName	Epilepsy Research
startingPage	13
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4d5295b938e388386aa8d768fb07e68d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f133861446fb809266effb816147841e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b640a0851ae3ed361179a5d20bac8e89
bibliographicCitation	Laux LC, Bebin EM, Checketts D, Chez M, Flamini R, Marsh ED, Miller I, Nichol K, Park Y, Segal E, Seltzer L, Szaflarski JP, Thiele EA, Weinstock A; CBD EAP study group. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results. Epilepsy Res. 2019 Aug;154():13–20. doi: 10.1016/j.eplepsyres.2019.03.015. PMID: 31022635.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d21dbbf3db8ba9cdc57c0208a0fe425 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d29c6e3e48d3bb77786b137ffecdbb3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a235c499e600e6d877bfe446ae3d6ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc158ad42ad6a573e806fd1fc43c97a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70c2eb5fc5a43d66b22309ade29322cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a129ef9e4f8310f0add4a62eba29a79 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4cc51e813aadf7f4751c509d7fd38a54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b46efcb3b167ca58910bad00784eac9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0355ef396d074effebf167df1bb6be16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5b3ab42fc0c4d022a1c1762e88315c8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8004ee991de780ce74b7dc7df2f3e74f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6618b199cb38fef562e57c8dc10a67b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90f7752a0a9742c565bd1d18c805fcbb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac1a63e6426c4540bd1ba188a604045f
date	201908
identifier	https://pubmed.ncbi.nlm.nih.gov/31022635 https://doi.org/10.1016/j.eplepsyres.2019.03.015
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587 https://portal.issn.org/resource/ISSN/0920-1211
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results
discusses	http://id.nlm.nih.gov/mesh/M0003266 http://id.nlm.nih.gov/mesh/M0001382
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D065768Q000188 http://id.nlm.nih.gov/mesh/D000069279Q000188 http://id.nlm.nih.gov/mesh/D000927Q000627 http://id.nlm.nih.gov/mesh/D004831Q000188 http://id.nlm.nih.gov/mesh/D002185Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D007223 http://id.nlm.nih.gov/mesh/D000081206 http://id.nlm.nih.gov/mesh/D003967Q000139 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D002675 http://id.nlm.nih.gov/mesh/D000069279Q000175 http://id.nlm.nih.gov/mesh/D002185Q000009 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D065768Q000175 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D000077260 http://id.nlm.nih.gov/mesh/D004831Q000175 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000927Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6654 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11492 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644019 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7621 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191

Total number of triples: 66.